Detalles de la búsqueda
1.
Challenges in assessing the immunization status of adults in Germany-lessons from a population-based VACCELERATE survey on polio vaccination.
Infection;
2024 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38806974
2.
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Infection;
52(3): 1191-1194, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38771466
3.
Insights into invasive fungal infection diagnostic and treatment capacities in tertiary care centres of Germany.
JAC Antimicrob Resist;
6(3): dlae083, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38812581
4.
Individual and institutional predisposing factors of MRSA surgical site infection and outcomes-a retrospective case-control-study in 14 European high-volume surgical centres.
JAC Antimicrob Resist;
6(2): dlae046, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38577701
5.
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry.
Haematologica;
2024 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38572549
6.
Perspectives of European Patient Advocacy Groups on Volunteer Registries and Vaccine Trials: VACCELERATE Survey Study.
JMIR Public Health Surveill;
10: e47241, 2024 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38573762
7.
Education pathways and key tasks for research nurses in Europe, results from a VACCELERATE online survey.
Nurse Educ Pract;
77: 103953, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38598884
8.
Necrotizing pancreatitis with invasive candidiasis and candidemia due to Candida albicans and pan-echinocandin-resistant Candidaglabrata.
Med Mycol Case Rep;
43: 100636, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38435498
9.
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022.
EClinicalMedicine;
71: 102553, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38533127
10.
The Cologne ECMM Excellence Center: A Two-Year Analysis of External Consultation Service for Invasive Fungal Infections.
Mycopathologia;
189(2): 25, 2024 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38466469
11.
Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM.
Lancet Infect Dis;
2024 Feb 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38346436
12.
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Infection;
52(3): 1125-1141, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38388854
13.
No Impact of Dietary Restrictions on the Risk for Infection in Pediatric Patients With Cancer: A Monocenter Analysis.
JCO Oncol Pract;
20(4): 503-508, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38261984
14.
Multicentric Study on the Clinical Mycology Capacity and Access to Antifungal Treatment in Portugal.
Mycopathologia;
189(1): 15, 2024 Jan 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38265528
15.
Predicting the next pandemic: VACCELERATE ranking of the WorldHealth Organization's Blueprint forAction toPreventEpidemics.
Travel Med Infect Dis;
57: 102676, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38061408
16.
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry.
Hematol Oncol;
42(1): e3240, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38050405
17.
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.
Leuk Lymphoma;
65(2): 199-208, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37966980
18.
Questioning the 14-day dogma in candidemia treatment duration.
Mycoses;
67(1): e13672, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37897148
19.
Laboratory and clinical management capacity for invasive fungal infections: the Italian landscape.
Infection;
52(1): 197-208, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37656348
20.
The Challenges of Vaccine Trial Participation among Underserved and Hard-to-Reach Communities: An Internal Expert Consultation of the VACCELERATE Consortium.
Vaccines (Basel);
11(12)2023 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38140188